Acuitas Investments, LLC Eton Pharmaceuticals, Inc. Transaction History
Acuitas Investments, LLC
- $106 Million
- Q4 2024
A detailed history of Acuitas Investments, LLC transactions in Eton Pharmaceuticals, Inc. stock. As of the latest transaction made, Acuitas Investments, LLC holds 185,824 shares of ETON stock, worth $3.29 Million. This represents 2.31% of its overall portfolio holdings.
Number of Shares
185,824
Previous 579,960
67.96%
Holding current value
$3.29 Million
Previous $3.48 Million
29.78%
% of portfolio
2.31%
Previous 1.66%
Shares
6 transactions
Others Institutions Holding ETON
# of Institutions
54Shares Held
9.1MCall Options Held
261KPut Options Held
500-
Opaleye Management Inc. Boston, MA2.78MShares$49.2 Million3.05% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.03MShares$18.2 Million0.0% of portfolio
-
Nantahala Capital Management, LLC New Canaan, CT999KShares$17.7 Million0.36% of portfolio
-
Westside Investment Management, Inc.575KShares$10.2 Million1.61% of portfolio
-
Eco R1 Capital, LLC San Francisco, CA566KShares$10 Million0.15% of portfolio
About Eton Pharmaceuticals, Inc.
- Ticker ETON
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 25,297,000
- Market Cap $448M
- Description
- Eton Pharmaceuticals, Inc., a specialty pharmaceutical company, focuses on developing and commercializing pharmaceutical products for rare diseases. The company offers Biorphen, a phenylephrine injection for the treatment of clinically important hypotension resulting primarily from vasodilation in the setting of anesthesia; Carglumic Acid for th...